Preventive action of nobiletin, a constituent of Aurantii Nobilis Pericarpium with anti-dementia activity, against amyloid-β peptide-induced neurotoxicity expression and memory impairment

Yakugaku Zasshi

Volumn 130, Issue 4, 2010, Pages 517-520

  Yamakuni, Tohru ^a   Nakajima, Akira ^a   Ohizumi, Yasushi ^a,b,c  

^a TOHOKU UNIVERSITY   (Japan)

^b YOKOHAMA COLLEGE OF PHARMACY   (Japan)

^c UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Alzheimer's disease; Amyloid peptide; Anti dementia activity; APP transgenic mouse; Memory impairment; Nobiletin

Indexed keywords

AMPA RECEPTOR; AMYLOID BETA PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUTAMIC ACID; NOBILETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CELL CULTURE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG INHIBITION; DRUG MECHANISM; DRUG STRUCTURE; ENZYME PHOSPHORYLATION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LONG TERM POTENTIATION; MEMORY DISORDER; MOUSE; NERVE CELL; NEUROTOXICITY; NONHUMAN; PROTEIN EXPRESSION; REVIEW; TRANSGENIC MOUSE;

EID: 77950415011     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.130.517     Document Type: Review

References (11)

1. Hardy J., Selkoe D. J., Science, 297, 353-356 (2002).
2. Nagase H., Omae N., Omori A., Nakagawasai O., Tadano T., Yokosuka A., Sashida Y., Mimaki Y., Yamakuni T., Ohizumi Y., Biochem. Biophys. Res. Commun., 337, 1330-1336 (2005).
3. Matsuzaki K., Yamakuni T., Hashimoto M., Haque A. M., Shido O., Mimaki Y., Sashida Y., Ohizumi Y., Neurosci. Lett., 400, 230-234 (2006).
4. Nakajima A., Yamakuni T., Matsuzaki K., Nakata N., Onozuka H., Yokosuka A., Sashida Y., Mimaki Y., Ohizumi Y., J. Pharmacol. Exp. Ther., 321, 784-790 (2007).
5. Onozuka H., Nakajima A., Matsuzaki K., Shin R.-W., Ogino K., Saigusa D., Tetsu N., Yokosuka A., Sashida Y., Mimaki Y., Yamakuni T., Ohizumi Y., J. Pharmacol. Exp. Ther., 326, 739-744 (2008).
6. Nakajima A., Yamakuni T., Haraguchi M., Omae N., Song S.-Y., Kato C., Tadano T., Yokosuka A., Sashida Y., Mimaki Y., Ohizumi Y., J. Pharmacol. Sci., 105, 122-126 (2007).
7. Yamamoto Y., Shioda N., Han F., Moriguchi S., Nakajima A., Yokosuka A., Mimaki Y., Sashida Y., Yamakuni T., Ohizumi Y., Fukunaga K., Brain Res., 1295, 218-229 (2009).
8. Shin R.-W., Ogino K., Shimabuku A., Taki T., Nakashima H., Ishihara T., Kitamoto T., Acta Neuropathol., 113, 627-636 (2007).
9. Matsuzaki K., Miyazaki K., Sakai S., Yawo H., Nakata N., Moriguchi S., Fukunaga K., Yokosuka A., Sashida Y., Mimaki Y., Yamakuni T., Ohizumi Y., Eur. J. Pharmacol., 578, 194-200 (2008).
10. Nagase H., Yamakuni T., Matsuzaki K., Maruyama Y., Kasahara J., Fukunaga K., Hinohara Y., Kondo S., Mimaki Y., Sashida Y., Tank A. W, Ohizumi Y., Biochemistry, 44, 13683-13691 (2005).
11. Vitolo O. V., Sant' Angelo A., Costanzo V., Battaglia F., Arancio O., Shelanski M., Proc. Natl. Acad. Sci. USA., 99, 13217-13221 (2002).